129 related articles for article (PubMed ID: 27541804)
1. Total Synthesis of Anti-Influenza Agents Zanamivir and Zanaphosphor via Asymmetric Aza-Henry Reaction.
Lin LZ; Fang JM
Org Lett; 2016 Sep; 18(17):4400-3. PubMed ID: 27541804
[TBL] [Abstract][Full Text] [Related]
2. A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity.
Shie JJ; Fang JM; Lai PT; Wen WH; Wang SY; Cheng YS; Tsai KC; Yang AS; Wong CH
J Am Chem Soc; 2011 Nov; 133(44):17959-65. PubMed ID: 21942552
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.
Lin CH; Chang TC; Das A; Fang MY; Hung HC; Hsu KC; Yang JM; von Itzstein M; Mong KK; Hsu TA; Lin CC
Org Biomol Chem; 2013 Jun; 11(24):3943-8. PubMed ID: 23695381
[TBL] [Abstract][Full Text] [Related]
4. Organocatalytic and scalable synthesis of the anti-influenza drugs zanamivir, laninamivir, and CS-8958.
Tian J; Zhong J; Li Y; Ma D
Angew Chem Int Ed Engl; 2014 Dec; 53(50):13885-8. PubMed ID: 25314609
[TBL] [Abstract][Full Text] [Related]
5. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
Cheng CK; Tsai CH; Shie JJ; Fang JM
Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
Francesconi V; Giovannini L; Santucci M; Cichero E; Costi MP; Naesens L; Giordanetto F; Tonelli M
Eur J Med Chem; 2018 Jul; 155():229-243. PubMed ID: 29886325
[TBL] [Abstract][Full Text] [Related]
7. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
Magano J
Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
[No Abstract] [Full Text] [Related]
8. A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity.
Lew W; Wu H; Mendel DB; Escarpe PA; Chen X; Laver WG; Graves BJ; Kim CU
Bioorg Med Chem Lett; 1998 Dec; 8(23):3321-4. PubMed ID: 9873727
[TBL] [Abstract][Full Text] [Related]
9. Structure-Based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-Resistant Influenza Viruses.
Fu L; Bi Y; Wu Y; Zhang S; Qi J; Li Y; Lu X; Zhang Z; Lv X; Yan J; Gao GF; Li X
J Med Chem; 2016 Jul; 59(13):6303-12. PubMed ID: 27341624
[TBL] [Abstract][Full Text] [Related]
10. Topology-Matching Design of an Influenza-Neutralizing Spiky Nanoparticle-Based Inhibitor with a Dual Mode of Action.
Nie C; Parshad B; Bhatia S; Cheng C; Stadtmüller M; Oehrl A; Kerkhoff Y; Wolff T; Haag R
Angew Chem Int Ed Engl; 2020 Sep; 59(36):15532-15536. PubMed ID: 32421225
[TBL] [Abstract][Full Text] [Related]
11. Chemical insight into the emergence of influenza virus strains that are resistant to Relenza.
Shidmoossavee FS; Watson JN; Bennet AJ
J Am Chem Soc; 2013 Sep; 135(36):13254-7. PubMed ID: 24001125
[TBL] [Abstract][Full Text] [Related]
12. Antiviral drugs for influenza 2012-2013.
Med Lett Drugs Ther; 2012 Dec; 54(1405):97-8. PubMed ID: 23223245
[No Abstract] [Full Text] [Related]
13. Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
Göktaş F; Vanderlinden E; Naesens L; Cesur N; Cesur Z
Bioorg Med Chem; 2012 Dec; 20(24):7155-9. PubMed ID: 23117173
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
[TBL] [Abstract][Full Text] [Related]
15. Resistance to neuraminidase inhibitors.
Dolin R
Clin Infect Dis; 2011 Feb; 52(4):438-9. PubMed ID: 21248366
[No Abstract] [Full Text] [Related]
16. Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.
Liu KC; Lee PS; Wang SY; Cheng YS; Fang JM; Wong CH
Bioorg Med Chem; 2011 Aug; 19(16):4796-802. PubMed ID: 21778065
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir).
Liu ZY; Wang B; Zhao LX; Li YH; Shao HY; Yi H; You XF; Li ZR
Bioorg Med Chem Lett; 2007 Sep; 17(17):4851-4. PubMed ID: 17611105
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities.
Ye D; Shin WJ; Li N; Tang W; Feng E; Li J; He PL; Zuo JP; Kim H; Nam KY; Zhu W; Seong BL; No KT; Jiang H; Liu H
Eur J Med Chem; 2012 Aug; 54():764-70. PubMed ID: 22795831
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.
Wen WH; Lin M; Su CY; Wang SY; Cheng YS; Fang JM; Wong CH
J Med Chem; 2009 Aug; 52(15):4903-10. PubMed ID: 19522501
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.
Das A; Adak AK; Ponnapalli K; Lin CH; Hsu KC; Yang JM; Hsu TA; Lin CC
Eur J Med Chem; 2016 Nov; 123():397-406. PubMed ID: 27487569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
